Outrageous Insulin Prices Now a Thing of the Past in U.S. After Government Initiates Monthly Cost of $35
Big Pharma companies Novo Nordisk, Eli Lilly, and Sanofi have all lowered the cost of their name-brand exogenous insulin products to comply with a new regulation that caps monthly list prices at $35.00. This is the ballpark price for both the privately insured and those on Medicare, and does not take into account any rebates […]
The post Outrageous Insulin Prices Now a Thing of the Past in U.S. After Government Initiates Monthly Cost of $35 appeared first on Good News Network.
from All News Archives – Good News Network https://ift.tt/SQPosq4